aMoon logo

aMoon

Venture Capital

Accelerating Cure

Founded 2016 Israel Ra'anana, Israel 59 employees Biotechnology, Health Care

38

Total Investments

27

Portfolio Companies

-

Exits

2

Industries

General Information

Industries Biotechnology, Health Care

Company Overview

Founded 2016
Employees 59
Location Israel Ra'anana, Israel
Website amoon.fund

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About aMoon

aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare. Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives. We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality. Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.

Recent Investments (38)

View All
Company Stage Amount Date
Series A •••••• Oct 2025
Series A •••••• Dec 2024
Series D •••••• Nov 2024
Series B •••••• May 2024
Series B •••••• Nov 2023
Portfolio company •••• ••••
Series C •••••• Sep 2023
Portfolio company •••• ••••
Series B •••••• Aug 2023
Portfolio company •••• ••••
Series A •••••• Nov 2022
Portfolio company •••• ••••
Series A •••••• Sep 2022
Portfolio company •••• ••••
Series C •••••• Aug 2022

See all 38 investments →

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes